Minocycline fails to slow vision loss in people with dry age-related macular degeneration

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health.

Does maternal weight influence breastfeeding success?

Study reviews literature to explore the influence of maternal body size on breastfeeding success, examining the onset of lactation, milk volume, and infant consumption among

April 15, 2024

Cardiovascular health disparities persist in puzzling ways, studies find

Last week’s election results may signal political winds sweeping attention away from diversity, equity, and inclusion, but new research papers again make the case that people

November 11, 2024

Harvard scholars call to eliminate orphan drug exemption in IRA to save Medicare more

While biopharma companies are calling foul over the fact that blockbuster drugs with multiple orphan designations remain eligible for government price negotiations under the Inflation

November 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.